Breast Cancer Trial, Recruiting NCT06593132 Sponsor: Ren,Yu Condition: Breast Cancer
Back to Breast Cancer

Breast Cancer Trial, Recruiting

NCT06593132
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have been diagnosed with breast cancer confirmed by a pathology test (tissue sample analysis)
  • People whose tumor is smaller than 5 cm and is classified as stage 0, I, or II
  • People who are having either a single-port endoscopic (keyhole) surgery or a traditional open surgery
  • Female patients between 20 and 70 years of age

Who may not be able to join:

  • People who have breast cancer in both breasts at the same time
  • People who are having breast reconstruction following breast-conserving surgery
  • People whose medical records or personal information are incomplete
  • People whose planned breast-conserving surgery was changed to a more extensive surgical procedure, such as a modified radical mastectomy or subcutaneous gland removal

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 6 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 15114822852

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Ren,Yu
Registry
ClinicalTrials.gov
Start date
1 January 2023
Est. completion
1 December 2024

Where this trial is recruiting

🇨🇳 China

Primary endpoints

Six months after operation SURVIVAL EFFECTS

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 6 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov